Viser 51 - 100 av 1617 resultater
Tid Selskap Tittel Sektor Kategori
27 Feb 2026
17:45 CET
SCHNEIDER ELECTRIC SE Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026 50202010 Electrical Components Other subject
27 Feb 2026
17:45 CET
SCHNEIDER ELECTRIC SE Nombre total de droits de vote et actions composant le capital social au 31 janvier 2026 50202010 Electrical Components Other subject
27 Feb 2026
17:45 CET
SCHNEIDER ELECTRIC SE Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025 50202010 Electrical Components Other subject
27 Feb 2026
17:40 CET
ENGIE ENGIE - ABB 65102000 Multi-utilities Other subject
27 Feb 2026
17:35 CET
WENDEL WENDEL: Share buybacks and liquidity agreement suspension 30202000 Diversified Financial Services Other subject
27 Feb 2026
17:35 CET
WENDEL WENDEL : Rachat d’actions et suspension du contrat de liquidité 30202000 Diversified Financial Services Other subject
27 Feb 2026
16:56 CET
BERNARD LOISEAU Communiqué sur la gouvernance de Bernard Loiseau SA 40501040 Restaurants and Bars Corporate life
27 Feb 2026
13:03 CET
SANOFI Communiqué de presse : Dupixent de Sanofi et Regeneron recommandé pour approbation dans l'UE dans le traitement de l'urticaire chronique spontanée chez les jeunes enfants dont les symptômes persistent malgré un traitement 20103015 Pharmaceuticals Other subject
27 Feb 2026
13:03 CET
SANOFI Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment 20103015 Pharmaceuticals Other subject
27 Feb 2026
12:20 CET
IPSEN Ipsen receives positive CHMP opinion for Ojemda® for the treatment as monotherapy of children with relapsed or refractory BRAF-altered pediatric low-grade glioma 20103015 Pharmaceuticals -
27 Feb 2026
12:20 CET
IPSEN Ipsen reçoit un avis positif du CHMP pour Ojemda® en monothérapie pour le traitement des enfants atteints de gliome pédiatrique de bas grade en rechute ou réfractaire, avec altération de BRAF 20103015 Pharmaceuticals -
27 Feb 2026
11:55 CET
SANOFI Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness 20103015 Pharmaceuticals -
27 Feb 2026
11:55 CET
SANOFI Communiqué de presse: L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif du CHMP comme traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil 20103015 Pharmaceuticals -
27 Feb 2026
10:40 CET
TIKEHAU CAPITAL Tikehau Capital: Disclosure of Shares Repurchases from 20 February 2026 to 26 February 2026 30202010 Asset Managers and Custodians Other subject
27 Feb 2026
10:40 CET
TIKEHAU CAPITAL Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 20 février 2026 au 26 février 2026 30202010 Asset Managers and Custodians Other subject
27 Feb 2026
10:00 CET
BONDUELLE Bonduelle - Statement of availability of the Half-Year Financial Report on December 31, 2025 45102020 Food Products Income
27 Feb 2026
10:00 CET
BONDUELLE Bonduelle - Mise à disposition du rapport financier semestriel au 31 décembre 2025 45102020 Food Products Income
27 Feb 2026
08:45 CET
AIR LIQUIDE(L-) Air Liquide et Holcim signent un accord visant à décarboner la production de ciment grâce à un projet de captage du carbone en Belgique 55201020 Specialty Chemicals Legal
27 Feb 2026
08:45 CET
AIR LIQUIDE(L-) Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium 55201020 Specialty Chemicals Legal
27 Feb 2026
08:15 CET
PRECIA Chiffre d'affaires consolidé 2025 & Acquisition Deftrade 50202025 Electronic Equipment: Gauges and Meters Corporate life
27 Feb 2026
07:30 CET
VALLOUREC Vallourec Fourth Quarter 2025 Results 60101030 Oil Equipment and Services Income
27 Feb 2026
07:30 CET
VALLOUREC Résultats du Quatrième Trimestre 2025 60101030 Oil Equipment and Services Income
27 Feb 2026
07:01 CET
BIOMERIEUX bioMérieux – 2025 Financial Results 20102010 Medical Equipment Other subject
27 Feb 2026
07:01 CET
BIOMERIEUX bioMérieux – Résultats annuels au 31 décembre 2025 20102010 Medical Equipment Other subject
26 Feb 2026
23:55 CET
SHOWROOMPRIVE RÉSULTAT DU 1ER SEMESTRE 2025 40401020 Apparel Retailers Sales, Income, Commercial results
26 Feb 2026
22:55 CET
STMICROELECTRONICS STMicroelectronics Publishes its 2025 Annual Report Form 20-F 10102010 Semiconductors Corporate life
26 Feb 2026
22:55 CET
STMICROELECTRONICS STMicroelectronics publie son formulaire 20-F pour l’année 2025 10102010 Semiconductors Corporate life
26 Feb 2026
22:14 CET
INVENTIVA Inventiva participera à quatre conférences investisseurs en mars 20103010 Biotechnology -
26 Feb 2026
22:14 CET
INVENTIVA Inventiva to Participate in Four Upcoming March Investor Conferences 20103010 Biotechnology -
26 Feb 2026
22:00 CET
INVENTIVA Inventiva to Participate in Four Upcoming March Investor Conferences 20103010 Biotechnology -
26 Feb 2026
22:00 CET
INVENTIVA Inventiva to Participate in Four Upcoming March Investor Conferences 20103010 Biotechnology -
26 Feb 2026
21:30 CET
GROUPE SFPI SFPI GROUPE: publication du Chiffre d\'affaires annuel 2025 50101035 Building Materials: Other Income
26 Feb 2026
21:30 CET
GROUPE SFPI SFPI GROUP: publication of 2025 annual sales 50101035 Building Materials: Other Income
26 Feb 2026
19:46 CET
EDF4.5%04DEC2069 EDF : EDF annonce le succès de son émission d’obligations senior vertes multi-tranches pour un montant nominal de 2,75 milliards d’euros 65101015 Conventional Electricity Corporate life
26 Feb 2026
19:46 CET
EDF4.5%04DEC2069 EDF: EDF announces the success of its senior green multi tranche bond issue for a nominal amount of 2.75 billion euros 65101015 Conventional Electricity Corporate life
26 Feb 2026
18:53 CET
HITECHPROS HITECHPROS - CHIFFRE D'AFFAIRES 2025 : 26,6M€ 10101010 Computer Services Commercial results
26 Feb 2026
18:36 CET
VALLOUREC Appointment of David Clarke As New Director of Vallourec 60101030 Oil Equipment and Services General meeting / Board Meeting
26 Feb 2026
18:36 CET
VALLOUREC DAVID CLARKE NOUVEL ADMINSTRATEUR DE VALLOUREC 60101030 Oil Equipment and Services General meeting / Board Meeting
26 Feb 2026
18:30 CET
ODIOT S.A. GreenSome Finance reiterates its "Buy" recommendation on ODIOT S.A following its capital increase 40204030 Luxury Items Legal
26 Feb 2026
18:30 CET
PAREF 2025 FULL-YEAR RESULTS 35102000 Diversified REITs Sales, Income, Commercial results
26 Feb 2026
18:30 CET
ODIOT S.A. GreenSome Finance confirme sa recommandation " Achat " pour ODIOT S.A à la suite de son augmentation de capital. 40204030 Luxury Items Legal
26 Feb 2026
18:26 CET
CASINO GUICHARD Casino Group Communication 45201010 Food Retailers and Wholesalers Other subject
26 Feb 2026
18:26 CET
CASINO GUICHARD Communication du Groupe Casino 45201010 Food Retailers and Wholesalers Other subject
26 Feb 2026
18:16 CET
FERM.CASINO MUNICIPAL CANNES Avis rectificatif du RAPPORT FINANCIER ANNUEL 2024/2025 (Format ESEF) 40501020 Casinos and Gambling Income
26 Feb 2026
18:15 CET
TELEPERFORMANCE TP: 2025 Annual Results 50205020 Professional Business Support Services General meeting / Board Meeting
26 Feb 2026
18:15 CET
PAREF PAREF renforce ses fondamentaux et engage son recentrage stratégique 35102000 Diversified REITs Sales, Income, Commercial results
26 Feb 2026
18:15 CET
TELEPERFORMANCE TP : Résultats annuels 2025 50205020 Professional Business Support Services General meeting / Board Meeting
26 Feb 2026
18:06 CET
FERM.CASINO MUNICIPAL CANNES Avis rectificatif du RAPPORT FINANCIER ANNUEL 2024/2025 (Format PDF) 40501020 Casinos and Gambling Income
26 Feb 2026
18:05 CET
CLARIANE SE Résultats annuels 2025 20101010 Health Care Facilities Income
26 Feb 2026
18:05 CET
CLARIANE SE Full-year 2025 results 20101010 Health Care Facilities Income